Summary
Researchers are testing CAR-T cell therapy, a cancer treatment, for use in severe autoimmune diseases. A 47-year-old woman with multiple autoimmune diseases saw significant improvement after receiving this therapy.
Key Facts
- CAR-T cell therapy uses a person's own immune cells to fight cancer by altering them to attack cancer cells.
- Originally for blood cancers, this therapy is now being tested for autoimmune diseases.
- A woman with severe autoimmune diseases improved after receiving CAR-T therapy.
- The therapy targets malfunctioning immune cells causing the diseases.
- The process involves modifying the patient's immune cells to identify and destroy specific immune cells.
- Researchers observed the woman's condition over 11 months, noting significant remission.
- Broader clinical trials are needed to fully understand the therapy's effectiveness for autoimmune diseases.
